This could be explained by the fact that Sema3C may trans-activate multiple receptor tyrosine kinases involved in the growth of prostate carcinoma cells, and potentially also implicated in resistance to androgen-deprivation therapies 90. The gene discussed is SEMA3C; the disease is prostate carcinoma.